Literature DB >> 17508135

Psychosocial interventions in people with multiple sclerosis: a review.

K S Malcomson1, L Dunwoody, A S Lowe-Strong.   

Abstract

BACKGROUND: Upon diagnosis individuals with Multiple Sclerosis (MS) must cope with both day to day and disease-related stressors in addition to unpredictable, fluctuating and confusing symptoms. Furthermore, disease progression may interfere with employment, family life, relationships and social activities. Psychosocial interventions aim to help individuals manage these psychological, social and emotional challenges. However, there are no specific guidelines available regarding the most effective intervention content, format or delivery. Therefore, a review of the research that has utilised these interventions, specifically those which, by definition, aimed to improve quality of life (QoL) and/or well-being in people with MS, was considered essential in order to identify which aspects of these interventions may help alleviate the psychosocial challenges associated with MS.
OBJECTIVES: To identify all randomised controlled trials (RCTs), quasi-experimental, cohort, case control and case series studies that have investigated psychosocial interventions in people with MS which aimed to improve QoL and/or well-being, to establish the methodological quality of such studies, and to determine the effectiveness of the interventions. SEARCH STRATEGY: Searches were carried out using computerised databases with predefined search terms; this was supplemented by manual searches of reference lists of all retrieved articles. Relevant journals were also hand searched. SELECTION CRITERIA: Studies written in English and published before January 2006, investigating the effectiveness of psychosocial interventions on QoL and/or well-being in people with MS, were eligible for inclusion. DATA COLLECTION AND ANALYSIS: Methodological quality was independently assessed by two reviewers using the Downs and Black quality scoring checklist. The qualitative and quantitative characteristics of studies were extracted using a data extraction sheet. MAIN
RESULTS: Thirty-three studies fulfilled the inclusion criteria; however, interventions varied widely in content, delivery and duration. Furthermore, failure to report full methodological details, as well as weaknesses in study design, reduced the strength of inferences that could be drawn from these studies. These notwithstanding, there were three studies of sufficient quality to provide some evidence regarding the value of education/information, goal setting, homework assignments, exercise, discussion forums and multidisciplinary team support. Thus, this review has identified the potential benefit of the aforementioned activities in the psychosocial management of this population. However, further well designed clinical trials are warranted to determine, definitively, the effectiveness, or otherwise, of these components.

Entities:  

Mesh:

Year:  2007        PMID: 17508135     DOI: 10.1007/s00415-006-0349-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Teaching coping skills enhances quality of life more than peer support: results of a randomized trial with multiple sclerosis patients.

Authors:  C E Schwartz
Journal:  Health Psychol       Date:  1999-05       Impact factor: 4.267

2.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

3.  Patient attitude as a function of disease state in multiple sclerosis.

Authors:  K J Evers; W Karnilowicz
Journal:  Soc Sci Med       Date:  1996-10       Impact factor: 4.634

4.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors:  S H Downs; N Black
Journal:  J Epidemiol Community Health       Date:  1998-06       Impact factor: 3.710

5.  CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials.

Authors:  D Moher
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

6.  Telephone-administered psychotherapy for depression.

Authors:  David C Mohr; Stacey L Hart; Laura Julian; Claudine Catledge; Lara Honos-Webb; Lea Vella; Edwin T Tasch
Journal:  Arch Gen Psychiatry       Date:  2005-09

7.  Efficacy of an energy conservation course for persons with multiple sclerosis.

Authors:  V Mathiowetz; K M Matuska; M E Murphy
Journal:  Arch Phys Med Rehabil       Date:  2001-04       Impact factor: 3.966

Review 8.  Emotional changes with multiple sclerosis and Parkinson's disease.

Authors:  S M Rao; S J Huber; R A Bornstein
Journal:  J Consult Clin Psychol       Date:  1992-06

9.  Evaluation of therapeutic riding (Sweden)/hippotherapy (United States). A single-subject experimental design study replicated in eleven patients with multiple sclerosis.

Authors:  Ann Hammer; Ylva Nilsagård; Anette Forsberg; Helena Pepa; Elisabeth Skargren; Birgitta Oberg
Journal:  Physiother Theory Pract       Date:  2005 Jan-Mar       Impact factor: 2.279

10.  Group psychotherapy: benefits in multiple sclerosis.

Authors:  J D Crawford; G P McIvor
Journal:  Arch Phys Med Rehabil       Date:  1985-12       Impact factor: 3.966

View more
  9 in total

1.  The effects of aerobic physical activity on adiposity in school-aged children and youth: a systematic review of randomized controlled trials.

Authors:  Michelle A Laframboise; Chris Degraauw
Journal:  J Can Chiropr Assoc       Date:  2011-12

2.  The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study.

Authors:  Alison M Mackay; Robert Buckingham; Raymond S Schwartz; Suzanne Hodgkinson; Roy G Beran; Dennis J Cordato
Journal:  Int J MS Care       Date:  2015 May-Jun

3.  Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

Authors:  João Carlos Correia de Sa; Laura Airas; Emmanuel Bartholome; Nikolaos Grigoriadis; Heinrich Mattle; Celia Oreja-Guevara; Jonathan O'Riordan; Finn Sellebjerg; Bruno Stankoff; Karl Vass; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

4.  Future MS care: a consensus statement of the MS in the 21st Century Steering Group.

Authors:  Peter Rieckmann; Alexey Boyko; Diego Centonze; Alasdair Coles; Irina Elovaara; Eva Havrdová; Otto Hommes; Jacques Lelorier; Sarah A Morrow; Celia Oreja-Guevara; Nick Rijke; Sven Schippling
Journal:  J Neurol       Date:  2012-08-31       Impact factor: 4.849

5.  Chinese herbal medicine and depression: the research evidence.

Authors:  Lee Butler; Karen Pilkington
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-10       Impact factor: 2.629

6.  Explaining stress coping behaviors in patients with multiple sclerosis based on the PRECEDE model: a qualitative directed content analysis.

Authors:  Atefeh Homayuni; Zahra Hosseini; Sedigheh Abedini
Journal:  BMC Psychiatry       Date:  2021-12-20       Impact factor: 3.630

7.  Effect of acceptance and commitment therapy on mood, sleep quality and quality of life in menopausal women: a randomized controlled trial.

Authors:  Zahra Monfaredi; Jamileh Malakouti; Mahmoud Farvareshi; Mojgan Mirghafourvand
Journal:  BMC Psychiatry       Date:  2022-02-11       Impact factor: 3.630

8.  Social support associated with quality of life in home care patients with intractable neurological disease in Japan.

Authors:  Tomoko Nishida; Eriko Ando; Hisataka Sakakibara
Journal:  Nurs Res Pract       Date:  2012-10-01

9.  Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis.

Authors:  Rona Moss-Morris; Laura Dennison; Lucy Yardley; Sabine Landau; Suzanne Roche; Paul McCrone; Trudie Chalder
Journal:  BMC Neurol       Date:  2009-08-23       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.